CONTERA PHARMA A/S: Financial statements 2021
CVR: 33062214
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CONTERA PHARMA A/S (CVR 33062214) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -24,154,462 and a net result of DKK -31,518,831 compared with DKK -12,258,975 the year before. Equity in the 2021 report amounted to DKK 163,442,081. The solvency ratio was 97.7%. The company had 13 employees in the financial year.
- Gross Profit
- DKK -24,154,462
- Profit/Loss
- DKK -31,518,831
- Equity
- DKK 163,442,081
- Total Assets
- DKK 167,212,607
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -24.2 mio. | -31.5 mio. | 163.4 mio. | 13 |
| 2020 | - | -9.7 mio. | -12.3 mio. | 195 mio. | 4 |
| 2019 | - | -1.2 mio. | -2 mio. | 17.8 mio. | 1 |
| 2018 | - | 1.5 mio. | -968 t. | 3.2 mio. | 2 |
| 2017 | - | 1.4 mio. | -419 t. | 1 mio. | 2 |
Official annual report
Find more companies like CONTERA PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of April 30, 2021, Sun Ho Kim has joined the board of directors of CONTERA PHARMA A/S.
As of April 30, 2021, Jung Yoon Um has left the board of directors of CONTERA PHARMA A/S.
CONTERA PHARMA A/S has published its annual report for 2020. Gross profit came to DKK -9,724,551, and the net result was DKK -12,258,975.
About CONTERA PHARMA A/S
CONTERA PHARMA A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CONTERA PHARMA ApS and CONCIT PHARMA ApS. The management consists of Thomas Nikolaj Sager. The board consists of Jae Young Lee (chair), Jee Hun Kim, Paul Ejnar Gremaud Kristjansen and Thomas Nikolaj Sager. The company is owned by Bukwang Pharmaceutical Co., Ltd. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 20,632,306 and a net result of DKK -4,783,781 compared with DKK -69,213,744 the year before. Equity in the 2025 report amounted to DKK 79,471,802.